FindTrial
Sign In

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2011-003184-29-FR
Enrollment
Unknown
Registered
2011-09-19
Start date
2013-04-30
Completion date
Unknown
Last updated
2013-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MedDRA version: 14.0 Level: LLT Classification code 10050436 Term: Prophylaxis against renal transplant rejection System Organ Class: 10042613 - Surgical and medical procedures

Interventions

Trade Name: ADVAGRAF Product Name: ADVAGRAF Pharmaceutical Form: Prolonged-release capsule, hard Trade Name: ADVAGRAF Product Name: ADVAGRAF Pharmaceutical Form: Prolonged-release capsule, hard

Sponsors

CHRU de Tours
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

France

Contacts

Public ContactDirection de la Recherche

CHRU de Tours

recherche.clinique@chu-tours.fr330247474747

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026